# Oral Melatonin in Critically Ill High-risk Patients

> **NCT00470821** · PHASE4 · COMPLETED · sponsor: **University of Milan** · enrollment: 96 (actual)

## Conditions studied

- Critically Ill Patients
- Mechanically Ventilated Patients

## Interventions

- **DRUG:** Oral melatonin 3mg BID
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00470821
- **Lead sponsor:** University of Milan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-04
- **Final completion:** 2010-05
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2010-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00470821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00470821, "Oral Melatonin in Critically Ill High-risk Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00470821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*